Eastman Kodak accelerates pharmaceutical supply with U.S.-made KSMs

Eastman Kodak accelerates pharmaceutical supply with U.S.-made KSMs
Kodak expands U.S. pharma output

Eastman Kodak is expanding its footprint in the pharmaceutical manufacturing sector by producing key starting materials (KSMs) domestically in the U.S. The company says this initiative is designed to improve speed, reliability, and compliance in supply chains.

Supported by robust technical expertise and certified quality and sustainability systems, Eastman Kodak aims to address critical needs in pharmaceutical manufacturing while promoting local production. The move aligns with broader efforts to enhance the resilience and quality standards of the U.S. pharmaceutical industry.

Eastman Kodak has recently expanded its operations through a partnership with Ateios Systems to promote capital-efficient battery manufacturing innovation, according to a previous report. The company also operates a 297,000-square-foot facility in Germany dedicated to the global distribution of SONORA printing plates, as detailed in an earlier article. These initiatives reflect Kodak's ongoing focus on technology-driven manufacturing.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.